These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9430866

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H, Dallas L, Nair S, Palmer J, Thaikandy S, Hutchison C.
    Toxins (Basel); 2020 May 12; 12(5):. PubMed ID: 32408589
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
    DeSoi CA, Sahm DF, Umans JG.
    Am J Kidney Dis; 1992 Oct 12; 20(4):354-60. PubMed ID: 1415203
    [Abstract] [Full Text] [Related]

  • 7. CAHP-210 dialyzer influence on intra-dialytic vancomycin removal.
    Lucksiri A, Scott MK, Mueller BA, Hamburger RJ, Sowinski KM.
    Nephrol Dial Transplant; 2002 Sep 12; 17(9):1649-54. PubMed ID: 12198218
    [Abstract] [Full Text] [Related]

  • 8. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.
    De Smet R, Dhondt A, Eloot S, Galli F, Waterloos MA, Vanholder R.
    Nephrol Dial Transplant; 2007 Jul 12; 22(7):2006-12. PubMed ID: 17468506
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK, Macias WL, Kraus MA, Clark WR, Carfagna MA, Mueller BA.
    Pharmacotherapy; 1997 Jul 12; 17(2):256-62. PubMed ID: 9085316
    [Abstract] [Full Text] [Related]

  • 11. Removal of high-molecular-weight solutes during high-efficiency and high-flux haemodialysis.
    Leypoldt JK, Cheung AK.
    Nephrol Dial Transplant; 1996 Feb 12; 11(2):329-35. PubMed ID: 8671788
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes.
    Böhler J, Reetze-Bonorden P, Keller E, Kramer A, Schollmeyer PJ.
    Eur J Clin Pharmacol; 1992 Feb 12; 42(6):635-9. PubMed ID: 1623904
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C, Tognotti D, Caponi L, Paolicchi A.
    BMC Nephrol; 2017 Feb 20; 18(1):68. PubMed ID: 28219328
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes.
    Zoer J, Schrander-van der Meer AM, van Dorp WT.
    Pharm World Sci; 1997 Aug 20; 19(4):191-6. PubMed ID: 9297732
    [Abstract] [Full Text] [Related]

  • 19. A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea-190H) to a standard high flux polysulfone dialyser membrane (FX-80) in the setting of extended hours haemodialysis.
    Kameshwar K, Damasiewicz MJ, Polkinghorne KR, Kerr PG.
    Nephrology (Carlton); 2022 Jun 20; 27(6):494-500. PubMed ID: 35195932
    [Abstract] [Full Text] [Related]

  • 20. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA.
    Am J Kidney Dis; 2005 Oct 20; 46(4):681-7. PubMed ID: 16183423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.